PDE
Phosphodiesterases (PDEs) are enzymes that hydrolyze cyclic nucleotides, such as cAMP and cGMP, into their inactive forms, playing a key role in regulating intracellular signaling pathways. PDE inhibitors are used in the treatment of various conditions, including cardiovascular diseases, erectile dysfunction, and respiratory disorders, due to their ability to modulate cyclic nucleotide levels. At CymitQuimica, we provide a range of PDE inhibitors to support your research in cell signaling, pharmacology, and therapeutic development.
Found 189 products for "PDE".
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Thioquinapiperifil dihydrochloride
CAS:Thioquinapiperifil dihydrochloride is a potent, selective PDE-5 inhibitor (IC50: 0.074 nM) for research.Formula:C24H29ClN6OSPurity:99.81%Color and Shape:Yellow SolidMolecular weight:485.05Ref: TM-T9773
1mg55.00€5mg123.00€1mL*10mM (DMSO)140.00€10mg177.00€25mg289.00€50mg371.00€100mg522.00€200mg687.00€Z21115
CAS:Z21115 is an orally effective phosphodiesterase 4 (PDE4) inhibitor that can inhibit PDE4D7 with an IC50 of 10.5 nM. It suppresses the expression of IL-6, TNF-α, and iNOS induced by Lipopolysaccharide. In a DSS-induced mouse colitis model, Z21115 demonstrates anti-inflammatory activity without significant toxicity at doses up to 1 g/kg.Formula:C20H20F2N2O4Molecular weight:390.38GSK4394835A
CAS:GSK4394835A is a reversible covalent inhibitor of PDE3B, with a pIC50 of 6.2. This compound is useful for research in cardiovascular diseases.Formula:C27H26BN3O6Molecular weight:499.33Ensifentrine tosylate
CAS:Ensifentrine (RPL-554) tosylate is an inhaled dual inhibitor of PDE3 and PDE4, with IC50 values of 0.4 nM and 1479 nM, respectively. By blocking these enzymes, it increases the levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in lung cells, leading to bronchodilation and inhibition of inflammatory cell activation and migration. Ensifentrine tosylate is used in the study of chronic obstructive pulmonary disease (COPD).Formula:C33H39N5O7SMolecular weight:649.76PDE5-IN-15
CAS:PDE5-IN-15 (compound 21) is a xanthine derivative and PDE5 inhibitor with IC50 values of 0.002 μM for hPDE5, 0.180 μM for bPDE6, 2.85 μM for bPDE1, and 2.22 μM for hPDE3. It exhibits good oral bioavailability in dogs and is applicable in research related to male erectile dysfunction.Formula:C21H23N5O3Molecular weight:393.44Deltasonamide 2 hydrochloride
Deltasonamide 2 hydrochloride is a competitive high-affinity PDEδ inhibitor with a Kd of approximately 385 pM.Formula:C30H40Cl2N6O4S2Purity:98%Color and Shape:SolidMolecular weight:683.71LT-104A
CAS:LT-104A is a potent PDE4 inhibitor that elevates intracellular cAMP levels (EC50 = 1.9 μM) and inhibits PDE4D3 activity (IC50 = 9.3 μM). It activates the cAMP-PKA-CREB anti-inflammatory pathway and suppresses NF-κB-related gene expression (Il1b and Nos2), making it applicable for research in inflammation-related diseases.Formula:C33H34O7Molecular weight:542.63ASP9831
CAS:ASP9831 is an orally active PDE4 inhibitor. It suppresses LPS-induced TNF-α production and exhibits anti-inflammatory properties. ASP9831 is useful in the study of steatohepatitis.Formula:C20H23N3O3Color and Shape:SolidMolecular weight:353.42PDE1-IN-7
CAS:PDE1-IN-7 (Compound 13h), with an IC50 value of 10 nM, selectively inhibits bPDE1. This compound demonstrates significant anti-fibrotic effects in a BDL-induced liver fibrosis rat model and is useful for research purposes in studying liver fibrosis [1].Formula:C32H36F2N2O6SColor and Shape:SolidMolecular weight:614.7
